• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溃疡性结肠炎的总体死亡率和特定病因死亡率:基于人群的起始队列研究的荟萃分析。

Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies.

作者信息

Jess Tine, Gamborg Michael, Munkholm Pia, Sørensen Thorkild I A

机构信息

Department of Medical Gastroenterology C, Herlev University Hospital, Copenhagen, Denmark.

出版信息

Am J Gastroenterol. 2007 Mar;102(3):609-17. doi: 10.1111/j.1572-0241.2006.01000.x.

DOI:10.1111/j.1572-0241.2006.01000.x
PMID:17156150
Abstract

OBJECTIVES

It remains debated whether patients with ulcerative colitis (UC) are at greater risk of dying and whether a possible alteration in mortality can be attributed to specific causes of death. We aimed to clarify this issue by conducting a meta-analysis of population-based inception cohort studies on overall and cause-specific mortality in patients with UC.

METHODS

The MEDLINE search engine and abstracts from international conferences were searched for relevant literature by use of explicit search criteria. STATA meta-analysis software was used to calculate pooled risk estimates (SMR, standardized mortality ratio, observed/expected deaths) of overall mortality and specific causes of death and to conduct metaregression analyses of the influence of specific variables on SMR.

RESULTS

Ten papers fulfilled the inclusion criteria, reporting SMRs varying from 0.7 to 1.4. The overall pooled estimate was 1.1 (95% confidence interval [CI] 0.9-1.2, P= 0.42). However, greater risk of dying was observed during the first years of follow-up, in patients with extensive colitis, and in patients from Scandinavia. Metaregression analysis showed an increase in SMR by increasing cohort size. UC-related mortality accounted for 17% of all deaths. Mortality from gastrointestinal diseases, nonalcoholic liver diseases, pulmonary embolisms, and respiratory diseases was increased whereas mortality from pulmonary cancer was reduced.

CONCLUSIONS

The overall risk of dying in patients with UC did not differ from that of the background population, although subgroups of patients were at greater risk of dying. The cause-of-death distribution seemed to differ from that of the background population.

摘要

目的

溃疡性结肠炎(UC)患者的死亡风险是否更高,以及死亡率的可能变化是否可归因于特定死因,目前仍存在争议。我们旨在通过对基于人群的起始队列研究进行荟萃分析,以阐明UC患者的总体和特定死因死亡率问题。

方法

使用明确的检索标准,在MEDLINE搜索引擎和国际会议摘要中检索相关文献。使用STATA荟萃分析软件计算总体死亡率和特定死因的合并风险估计值(标准化死亡比,SMR,观察到的/预期的死亡数),并对特定变量对SMR的影响进行元回归分析。

结果

十篇论文符合纳入标准,报告的SMR在0.7至1.4之间。总体合并估计值为1.1(95%置信区间[CI]0.9 - 1.2,P = 0.42)。然而,在随访的最初几年、广泛性结肠炎患者以及来自斯堪的纳维亚半岛的患者中,观察到更高的死亡风险。元回归分析显示,随着队列规模的增加,SMR升高。UC相关死亡率占所有死亡的17%。胃肠道疾病、非酒精性肝病、肺栓塞和呼吸系统疾病的死亡率增加,而肺癌死亡率降低。

结论

UC患者的总体死亡风险与背景人群无异,尽管部分亚组患者的死亡风险更高。死因分布似乎与背景人群不同。

相似文献

1
Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies.溃疡性结肠炎的总体死亡率和特定病因死亡率:基于人群的起始队列研究的荟萃分析。
Am J Gastroenterol. 2007 Mar;102(3):609-17. doi: 10.1111/j.1572-0241.2006.01000.x.
2
Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies.克罗恩病患者患肠癌风险增加:基于人群队列研究的荟萃分析
Am J Gastroenterol. 2005 Dec;100(12):2724-9. doi: 10.1111/j.1572-0241.2005.00287.x.
3
Low mortality in ulcerative colitis and Crohn's disease in three regional centers in England.英国三个地区中心溃疡性结肠炎和克罗恩病的低死亡率
Am J Gastroenterol. 2001 Feb;96(2):501-7. doi: 10.1111/j.1572-0241.2001.03466.x.
4
Causes of death in patients with celiac disease in a population-based Swedish cohort.瑞典一项基于人群队列研究中乳糜泻患者的死因
Arch Intern Med. 2003 Jul 14;163(13):1566-72. doi: 10.1001/archinte.163.13.1566.
5
Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.长期暴露于交通相关空气污染对荷兰呼吸道和心血管疾病死亡率的影响:荷兰长期队列空气污染研究(NLCS-AIR研究)
Res Rep Health Eff Inst. 2009 Mar(139):5-71; discussion 73-89.
6
Increased risk of cancer in ulcerative colitis: a population-based cohort study.溃疡性结肠炎患者患癌风险增加:一项基于人群的队列研究。
Am J Gastroenterol. 1999 Apr;94(4):1047-52. doi: 10.1111/j.1572-0241.1999.01012.x.
7
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).溃疡性结肠炎最初10年的临床病程:基于人群的发病队列研究结果(IBSEN研究)
Scand J Gastroenterol. 2009;44(4):431-40. doi: 10.1080/00365520802600961.
8
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.类风湿关节炎患者心血管疾病死亡风险:观察性研究的荟萃分析
Arthritis Rheum. 2008 Dec 15;59(12):1690-7. doi: 10.1002/art.24092.
9
Mortality among workers at the Savannah River Site.萨凡纳河工厂工人的死亡率。
Am J Ind Med. 2007 Dec;50(12):881-91. doi: 10.1002/ajim.20511.
10
CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.HIV感染中CD4+细胞指导下的抗逆转录病毒治疗中断:一项荟萃分析。
AIDS Rev. 2008 Oct-Dec;10(4):236-44.

引用本文的文献

1
The global burden of inflammatory bowel disease: from 2025 to 2045.2025年至2045年炎症性肠病的全球负担
Nat Rev Gastroenterol Hepatol. 2025 Jul 18. doi: 10.1038/s41575-025-01097-1.
2
Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis in induction and maintenance: systematic literature review and Bayesian network meta-analysis.中重度活动性溃疡性结肠炎诱导和维持期先进疗法的疗效与安全性:系统文献综述和贝叶斯网络荟萃分析
J Comp Eff Res. 2025 May;14(5):e240225. doi: 10.57264/cer-2024-0225. Epub 2025 Mar 17.
3
Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis.
在中度至重度活动性溃疡性结肠炎中,依曲莫德与奥扎莫德疗效结果的匹配调整间接比较。
J Comp Eff Res. 2025 Apr;14(4):e240193. doi: 10.57264/cer-2024-0193. Epub 2025 Feb 24.
4
Global patterns in the epidemiology, cancer risk, and surgical implications of inflammatory bowel disease.炎症性肠病的流行病学、癌症风险及手术影响的全球模式
Gastroenterol Rep (Oxf). 2024 Jul 9;12:goae053. doi: 10.1093/gastro/goae053. eCollection 2024.
5
Cost-Effectiveness of Vedolizumab as a First-Line Advanced Therapy Versus Adalimumab Treatment Sequences for Ulcerative Colitis in Italy.在意大利,维多珠单抗作为溃疡性结肠炎一线高级疗法与阿达木单抗治疗方案的成本效益比较。
Pharmacoecon Open. 2024 Sep;8(5):701-714. doi: 10.1007/s41669-024-00497-4. Epub 2024 Jun 11.
6
Oral manifestations serve as potential signs of ulcerative colitis: A review.口腔表现可作为溃疡性结肠炎的潜在征象:综述。
Front Immunol. 2022 Sep 29;13:1013900. doi: 10.3389/fimmu.2022.1013900. eCollection 2022.
7
Cost-effectiveness Analysis of Subcutaneous Infliximab for Inflammatory Bowel Diseases in Sequential Biologic Treatment.生物序贯治疗中皮下注射英夫利昔单抗治疗炎症性肠病的成本效果分析。
Inflamm Bowel Dis. 2023 Jun 1;29(6):898-913. doi: 10.1093/ibd/izac160.
8
Ileo-rectal anastomosis in ulcerative colitis-Long-term outcome, failure and risk of cancer at a tertiary centre.溃疡性结肠炎的回直肠吻合术-三级中心的长期结果、失败和癌症风险。
Colorectal Dis. 2022 Dec;24(12):1535-1542. doi: 10.1111/codi.16237. Epub 2022 Jul 11.
9
Increased Lifetime Risk of Intestinal Complications and Extraintestinal Manifestations in Crohn's Disease and Ulcerative Colitis.克罗恩病和溃疡性结肠炎患者肠道并发症及肠外表现的终生风险增加。
Gastroenterol Hepatol (N Y). 2022 Jan;18(1):32-43.
10
Natural history of inflammatory bowel disease: a comparison between the East and the West.炎症性肠病的自然史:东西方比较
Intest Res. 2022 Oct;20(4):418-430. doi: 10.5217/ir.2021.00104. Epub 2021 Dec 2.